Patents by Inventor Murat Artan

Murat Artan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF REGULATING LIFESPAN USING TRANSGENIC CAENORHABDITIS ELEGANS
    Publication number: 20170339930
    Abstract: The present disclosure relates to transgenic Caenorhabditis elegans including, in sensory neurons, Channelrhodopsin 2 (ChR2)::Green Fluorescence Protein (GFP) DNA in which the ChR2 gene and the GFP gene are linked, a method of producing the same, a method of regulating the lifespan thereof, and a method of screening an aging regulation candidate by using the same. The present disclosure may also provide an animal model for research into prevention/treatment of aging-related diseases by regulating the lifespan of an animal on a subject level and a method of screening a drug candidate for prevention/treatment of aging-related diseases.
    Type: Application
    Filed: May 16, 2017
    Publication date: November 30, 2017
    Inventors: SEUNG-JAE LEE, MURAT ARTAN, DAE-EUN JEONG
  • Method for manufacturing transgenic caenorhabditis elegans with DNA methyltransferase and use thereof
    Patent number: 9681648
    Abstract: Provided are transgenic Caenorhabditis elegans (C. elegans) overexpressing DNA methyltransferase 3a (Dnmt3a) and a method of producing the same. According to the method, a specific mechanism and related factors for DNA methylation mediated by Dnmt3a may be found, and a critical gene for regulating the life span of C. elegans may be identified, and therefore C. elegans may be used as an animal model for screening a drug for a DNA methylation-related disease.
    Type: Grant
    Filed: October 14, 2015
    Date of Patent: June 20, 2017
    Assignee: POSTECH ACADEMY-INDUSTRY FOUNDATION
    Inventors: Tae Young Roh, Seung-Jae Lee, Murat Artan, Yuna Kim, Hong Gil Nam
  • Method for Manufacturing Transgenic Caenorhabditis Elegans with DNA Methyltransferase and Use Thereof
    Publication number: 20170020116
    Abstract: Provided are transgenic Caenorhabditis elegans (C. elegans) overexpressing DNA methyltransferase 3a (Dnmt3a) and a method of producing the same. According to the method, a specific mechanism and related factors for DNA methylation mediated by Dnmt3a may be found, and a critical gene for regulating the life span of C. elegans may be identified, and therefore C. elegans may be used as an animal model for screening a drug for a DNA methylation-related disease.
    Type: Application
    Filed: October 14, 2015
    Publication date: January 26, 2017
    Inventors: Tae Young Roh, Seung-Jae Lee, Murat Artan, Yuna Kim, Hong Gil Nam